Spiro-fused pyrrolidine derivatives as desubiquitination (DUB) enzyme inhibitors

MA43701AUndetermined Publication Date: 2018-11-28MISSION THERAPEUTICS LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MA43701
Authority / Receiving Office
MA · MA
Patent Type
Applications
Current Assignee / Owner
Priority Date
2016-03-04
Filing Date
2017-03-02
Publication Date
2018-11-28
Patent Text Reader
Need to check novelty before this filing date? Find Prior Art
No text content released.